Kunadian V, Dunford JR, Swarbrick D, Halaby R, Ajari O, Cochet M, Feeney K, Larkin E, Gonzalez GR, Govindavarjhulla A, Nethala D, Patel H, Guddeti RR, Khan F, Kumar S, Patel S, Saddala P, Serla VV, Zacarkim M, Yadav D, Gibson CM. Triple Antiplatelet Therapy and Combinations with Oral Anticoagulants After Stent Implantation. Interv Cardiol Clin. 2013 Oct;2(4):595-606. doi: 10.1016/j.iccl.2013.05.007. Epub 2013 Jul 13.
Burke DA, Pinto DS. Role of Parenteral Agents in Percutaneous Coronary Intervention for Stable Patients. Interv Cardiol Clin. 2013 Oct;2(4):537-551. doi: 10.1016/j.iccl.2013.06.004. Epub 2013 Jul 20.
Stroescu R, Micle I, Marginean O, Bizerea T, Marazan M, Puiu M, Sipos C, Doros G. Is small for gestational age status associated with an increased risk of atherogenesis?. Maedica (Bucur). 2013 Sep;8(4):315-20.
Nathan A, Mauri L. Diabetic heart disease and interventional cardiology: how can clinical outcomes be improved? Revascularization guided by hemodynamic parameters (fractional flow reserve). Rev Esp Cardiol (Engl Ed). 2013 Jun;66(6):432-4. doi: 10.1016/j.rec.2012.12.013. Epub 2013 Apr 11.
Reynolds MR, Hawasli AH, Murphy RK, Ray WZ, Simpson JR, Drzymala RE, Rich KM. Acute Hemorrhage Following Gamma Knife Radiosurgery to a Clival Meningioma. J Spine Neurosurg. 2013 Feb 1;2(2):108. doi: 10.4172/2325-9701.1000108.
Shimada YJ, Passeri JJ, Baggish AL, O’Callaghan C, Lowry PA, Yannekis G, Abbara S, Ghoshhajra BB, Rothman RD, Ho CY, Januzzi JL, Seidman CE, Fifer MA. Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathy. JACC Heart Fail. 2013 Dec;1(6):480-7. doi: 10.1016/j.jchf.2013.09.001. Epub 2013 Oct 24.
Januzzi JL Jr, Felker GM. Surfing the biomarker tsunami at JACC: heart failure. JACC Heart Fail. 2013 Jun;1(3):213-5. doi: 10.1016/j.jchf.2013.03.007. Epub 2013 Jun 3.
Torina A, Blanda V, Antoci F, Scimeca S, D’Agostino R, Scariano E, Piazza A, Galluzzo P, Giudice E, Caracappa S. A Molecular survey of Anaplasma spp., Rickettsia spp., Ehrlichia canis and Babesia microti in foxes and fleas from Sicily. Transbound Emerg Dis. 2013 Nov;60 Suppl 2:125-30. doi: 10.1111/tbed.12137.
Moon BS, Gilbert NF, Cannon CP, Lin PP, Lewis VO. Distal Femur Allograft Prosthetic Composite Reconstruction for Short Proximal Femur Segments following Tumor Resection. Adv Orthop. 2013;2013:397456. doi: 10.1155/2013/397456. Epub 2013 Nov 17.
Kalim S, Clish CB, Wenger J, Elmariah S, Yeh RW, Deferio JJ, Pierce K, Deik A, Gerszten RE, Thadhani R, Rhee EP. A plasma long-chain acylcarnitine predicts cardiovascular mortality in incident dialysis patients. J Am Heart Assoc. 2013 Dec 5;2(6):e000542. doi: 10.1161/JAHA.113.000542.
Kramer DB, Zimetbaum PJ. Ectopy and expectations: can we predict atrial fibrillation, and should we try?. Ann Intern Med. 2013 Dec 3;159(11):787-8. doi: 10.7326/0003-4819-159-11-201312030-00014.
Brener SJ, Kereiakes DJ, Simonton CA, Rizvi A, Newman W, Mastali K, Wang JC, Caputo R, Smith RS Jr, Ying SW, Cutlip DE, Stone GW. Everolimus-eluting stents in patients undergoing percutaneous coronary intervention: final 3-year results of the Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery Lesions trial. Am Heart J. 2013 Dec;166(6):1035-42. doi: 10.1016/j.ahj.2013.08.030. Epub 2013 Oct 31.
Inglessis I, Elmariah S, Rengifo-Moreno PA, Margey R, O’Callaghan C, Cruz-Gonzalez I, Baron S, Mehrotra P, Tan TC, Hung J, Demirjian ZN, Buonanno FS, Ning M, Silverman SB, Cubeddu RJ, Pomerantsev E, Schainfeld RM, Dec GW Jr, Palacios IF. Long-term experience and outcomes with transcatheter closure of patent foramen ovale. JACC Cardiovasc Interv. 2013 Nov;6(11):1176-83. doi: 10.1016/j.jcin.2013.06.013.
Gada H, Kirtane AJ, Newman W, Sanz M, Hermiller JB, Mahaffey KW, Cutlip DE, Sudhir K, Hou L, Koo K, Stone GW. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions). JACC Cardiovasc Interv. 2013 Dec;6(12):1263-6. doi: 10.1016/j.jcin.2013.07.009. Epub 2013 Nov 13.
Zhang M, Shubina M, Morrison F, Turchin A. Following the money: copy-paste of lifestyle counseling documentation and provider billing. BMC Health Serv Res. 2013 Oct 2;13:377. doi: 10.1186/1472-6963-13-377.
Hassan S, Karpova Y, Flores A, D’Agostino R Jr, Kulik G. Surgical stress delays prostate involution in mice. PLoS One. 2013 Nov 6;8(11):e78175. doi: 10.1371/journal.pone.0078175. eCollection 2013.
Elmariah S, Palacios IF, McAndrew T, Hueter I, Inglessis I, Baker JN, Kodali S, Leon MB, Svensson L, Pibarot P, Douglas PS, Fearon WF, Kirtane AJ, Maniar HS, Passeri JJ; PARTNER Investigators. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A). Circ Cardiovasc Interv. 2013 Dec;6(6):604-14. doi: 10.1161/CIRCINTERVENTIONS.113.000650. Epub 2013 Nov 12.
Freemantle N, Marston L, Walters K, Wood J, Reynolds MR, Petersen I. Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research. BMJ. 2013 Nov 11;347:f6409. doi: 10.1136/bmj.f6409.
Pastor-Pérez FJ, Manzano-Fernández S, Goya-Esteban R, Pascual-Figal DA, Bravo IP, Barquero-Pérez O, Rojo-Álvarez JL, Januzzi JL, Chavarri MV, García-Alberola A. Heart rate control in chronic heart failure: resting versus mean heart rate with prolonged ambulatory ECG recording. Int J Cardiol. 2013 Dec 10;170(2):e45-7. doi: 10.1016/j.ijcard.2013.10.071. Epub 2013 Oct 26.
Xanthakis V, Larson MG, Wollert KC, Aragam J, Cheng S, Ho J, Coglianese E, Levy D, Colucci WS, Michael Felker G, Benjamin EJ, Januzzi JL, Wang TJ, Vasan RS. Association of novel biomarkers of cardiovascular stress with left ventricular hypertrophy and dysfunction: implications for screening. J Am Heart Assoc. 2013 Nov 7;2(6):e000399. doi: 10.1161/JAHA.113.000399.
Beach SR, Januzzi JL, Mastromauro CA, Healy BC, Beale EE, Celano CM, Huffman JC. Patient Health Questionnaire-9 score and adverse cardiac outcomes in patients hospitalized for acute cardiac disease. J Psychosom Res. 2013 Nov;75(5):409-13. doi: 10.1016/j.jpsychores.2013.08.001. Epub 2013 Aug 13.
Wang TY, McCoy LA, Messenger JC, Neely ML, Ho KK, Roe MT, Anderson HV. Cardiac biomarker measurement after elective percutaneous coronary interventions in older patients: insights from the National Cardiovascular Data Registry. Am Heart J. 2013 Nov;166(5):927-34. doi: 10.1016/j.ahj.2013.09.007. Epub 2013 Oct 4.
Elmariah S, Budoff MJ, Delaney JA, Hamirani Y, Eng J, Fuster V, Kronmal RA, Halperin JL, O’Brien KD. Risk factors associated with the incidence and progression of mitral annulus calcification: the multi-ethnic study of atherosclerosis. Am Heart J. 2013 Nov;166(5):904-12. doi: 10.1016/j.ahj.2013.08.015. Epub 2013 Sep 26.
Ellrodt AG, Fonarow GC, Schwamm LH, Albert N, Bhatt DL, Cannon CP, Hernandez AF, Hlatky MA, Luepker RV, Peterson PN, Reeves M, Smith EE. Synthesizing lessons learned from get with the guidelines: the value of disease-based registries in improving quality and outcomes. Circulation. 2013 Nov 26;128(22):2447-60. doi: 10.1161/01.cir.0000435779.48007.5c. Epub 2013 Oct 28.
Rodriguez F, Cannon CP, Steg PG, Kumbhani DJ, Goto S, Smith SC, Eagle KA, Ohman EM, Umez-Eronini AA, Hoffman E, Bhatt DL; REACH Registry Investigators. Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH Registry. Clin Cardiol. 2013 Dec;36(12):721-7. doi: 10.1002/clc.22217. Epub 2013 Oct 25.
Yassin A, Doros G. Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss. Clin Obes. 2013 Jun;3(3-4):73-83. doi: 10.1111/cob.12022. Epub 2013 Jun 19.
Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, Ciszewski A, Vakili H, Hoffman EB, Farkouh ME, Cannon CP. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA. 2013 Oct 23;310(16):1711-20. doi: 10.1001/jama.2013.279206.
Waks JW, Zimetbaum PJ. Dabigatran etexilate for thromboembolic prophylaxis in non-valvular atrial fibrillation: the RE-LY study and substudies with commentary. Expert Rev Cardiovasc Ther. 2013 Nov;11(11):1461-71. doi: 10.1586/14779072.2013.849572. Epub 2013 Oct 23.
Abdallah MS, Wang K, Magnuson EA, Spertus JA, Farkouh ME, Fuster V, Cohen DJ; FREEDOM Trial Investigators. Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial. JAMA. 2013 Oct 16;310(15):1581-90. doi: 10.1001/jama.2013.279208.
Martin SS, Blaha MJ, Toth PP, Joshi PH, McEvoy JW, Ahmed HM, Elshazly MB, Swiger KJ, Michos ED, Kwiterovich PO, Kulkarni KR, Chimera J, Cannon CP, Blumenthal RS, Jones SR. Very large database of lipids: rationale and design. Clin Cardiol. 2013 Nov;36(11):641-8. doi: 10.1002/clc.22214. Epub 2013 Oct 1.
Gaggin HK, Motiwala S, Bhardwaj A, Parks KA, Januzzi JL Jr. Soluble concentrations of the interleukin receptor family member ST2 and β-blocker therapy in chronic heart failure. Circ Heart Fail. 2013 Nov;6(6):1206-13. doi: 10.1161/CIRCHEARTFAILURE.113.000457. Epub 2013 Oct 10.
Dmitrienko A, D’Agostino R Sr. Traditional multiplicity adjustment methods in clinical trials. Stat Med. 2013 Dec 20;32(29):5172-218. doi: 10.1002/sim.5990. Epub 2013 Sep 30.
Dabelea D, Talton JW, D’Agostino R Jr, Wadwa RP, Urbina EM, Dolan LM, Daniels SR, Marcovina SM, Hamman RF. Cardiovascular risk factors are associated with increased arterial stiffness in youth with type 1 diabetes: the SEARCH CVD study. Diabetes Care. 2013 Dec;36(12):3938-43. doi: 10.2337/dc13-0851. Epub 2013 Oct 7.
Kaul P, Tanguay JF, Newby LK, Hochman JS, Westerhout CM, Califf RM, Tricoci P, Gibson CM, Giugliano RP, Harrington RA, Van de Werf F, Armstrong PW. Association between bleeding and mortality among women and men with high-risk acute coronary syndromes: insights from the Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes (EARLY ACS) trial. Am Heart J. 2013 Oct;166(4):723-8. doi: 10.1016/j.ahj.2013.07.014. Epub 2013 Sep 5.
Huffman JC, Beach SR, Suarez L, Mastromauro CA, DuBois CM, Celano CM, Rollman BL, Januzzi JL. Design and baseline data from the Management of Sadness and Anxiety in Cardiology (MOSAIC) randomized controlled trial. Contemp Clin Trials. 2013 Nov;36(2):488-501. doi: 10.1016/j.cct.2013.09.012. Epub 2013 Oct 1.
Cavender MA, Rassi AN, Fonarow GC, Cannon CP, Peacock WF, Laskey WK, Hernandez AF, Peterson ED, Cox M, Grau-Sepulveda M, Schwamm LH, Bhatt DL. Relationship of race/ethnicity with door-to-balloon time and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: findings from Get With the Guidelines-Coronary Artery Disease. Clin Cardiol. 2013 Dec;36(12):749-56. doi: 10.1002/clc.22213. Epub 2013 Sep 24.
Stone GW, Witzenbichler B, Godlewski J, Dambrink JH, Ochala A, Chowdhary S, El-Omar M, Neunteufl T, Metzger DC, Dizon JM, Wolff SD, Brener SJ, Mehran R, Maehara A, Gibson CM. Intralesional abciximab and thrombus aspiration in patients with large anterior myocardial infarction: one-year results from the INFUSE-AMI trial. Circ Cardiovasc Interv. 2013 Oct 1;6(5):527-34. doi: 10.1161/CIRCINTERVENTIONS.113.000644. Epub 2013 Oct 1.
Elmariah S, Shah RV, Kostis WJ, Hinson JT, Picard MH, Palacios IF. Coronary sinus pacing for the management of right ventricular and atrial infarction with isolated right ventricular pulsus alternans. Tex Heart Inst J. 2013;40(4):497-9.
Toth PP, Barter PJ, Rosenson RS, Boden WE, Chapman MJ, Cuchel M, D’Agostino RB Sr, Davidson MH, Davidson WS, Heinecke JW, Karas RH, Kontush A, Krauss RM, Miller M, Rader DJ. High-density lipoproteins: a consensus statement from the National Lipid Association. J Clin Lipidol. 2013 Sep-Oct;7(5):484-525. doi: 10.1016/j.jacl.2013.08.001. Epub 2013 Aug 11.
Mogabgab O, Wiviott SD, Cannon CP, Sloan S, Sabatine MS, Antman EM, Braunwald E, Giugliano RP. Circadian variation of stent thrombosis and the effect of more robust platelet inhibition: a post hoc analysis of the TRITON-TIMI 38 trial. J Cardiovasc Pharmacol Ther. 2013 Nov;18(6):555-9. doi: 10.1177/1074248413497534. Epub 2013 Sep 24.
Palmerini T, Brener SJ, Genereux P, Maehara A, Della Riva D, Mariani A, Witzenbichler B, Godlewski J, Parise H, Dambrink JH, Ochala A, Fahy M, Xu K, Gibson CM, Stone GW. Relation between white blood cell count and final infarct size in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (from the INFUSE AMI trial). Am J Cardiol. 2013 Dec 15;112(12):1860-6. doi: 10.1016/j.amjcard.2013.08.010. Epub 2013 Sep 21.
Dangas GD, Serruys PW, Kereiakes DJ, Hermiller J, Rizvi A, Newman W, Sudhir K, Smith RS Jr, Cao S, Theodoropoulos K, Cutlip DE, Lansky AJ, Stone GW. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). JACC Cardiovasc Interv. 2013 Sep;6(9):914-22. doi: 10.1016/j.jcin.2013.05.005.
Kumar K, Zimetbaum PJ. Antiarrhythmic drugs 2013: state of the art. Curr Cardiol Rep. 2013 Oct;15(10):410. doi: 10.1007/s11886-013-0410-2.
Cavalcanti AL, de Oliveira KF, Xavier AF, Pinto DS, Vieira FF. Evaluation of total soluble solids content (TSSC) and endogenous pH in antimicrobials of pediatric use. Indian J Dent Res. 2013 Jul-Aug;24(4):498-501. doi: 10.4103/0970-9290.118386.
Yang X, Pinto DS, Chakrabarti AK. Optimizing reperfusion in patients with STEMI: a critical evaluation of pharmacologic and non-pharmacologic strategies. Am J Cardiovasc Drugs. 2013 Dec;13(6):399-406. doi: 10.1007/s40256-013-0045-0.
Main ML, Grayburn PA, Lang RM, Goldman JH, Gibson CM, Sherwin P, DeMaria AN. Effect of Optison on pulmonary artery systolic pressure and pulmonary vascular resistance. Am J Cardiol. 2013 Nov 15;112(10):1657-61. doi: 10.1016/j.amjcard.2013.07.026. Epub 2013 Sep 13.
Masoudi FA, Ponirakis A, Yeh RW, Maddox TM, Beachy J, Casale PN, Curtis JP, De Lemos J, Fonarow G, Heidenreich P, Koutras C, Kremers M, Messenger J, Moussa I, Oetgen WJ, Roe MT, Rosenfield K, Shields TP Jr, Spertus JA, Wei J, White C, Young CH, Rumsfeld JS. Cardiovascular care facts: a report from the national cardiovascular data registry: 2011. J Am Coll Cardiol. 2013 Nov 19;62(21):1931-1947. doi: 10.1016/j.jacc.2013.05.099. Epub 2013 Sep 18.
Klingbeil MF, Xavier FC, Sardinha LR, Severino P, Mathor MB, Rodrigues RV, Pinto DS Jr. Cytotoxic effects of mistletoe (Viscum album L.) in head and neck squamous cell carcinoma cell lines. Oncol Rep. 2013 Nov;30(5):2316-22. doi: 10.3892/or.2013.2732. Epub 2013 Sep 10.
Patrick WL, Patel C, Guddeti R, Narayan A, Maddaleni M, Kumar S, Dolma K, Serla VV, Sangha M, Govindavarjhulla A, Saddala P, Singh P, Halaby R, Gibson CM. Is there a need for “triple therapy”? Role of anticoagulation with dual antiplatelet therapy in acute coronary syndromes (ATLAS Study & TRAP Study). Curr Cardiol Rep. 2013 Oct;15(10):411. doi: 10.1007/s11886-013-0411-1.
Bagai A, White JA, Lokhnygina Y, Giugliano RP, Van de Werf F, Montalescot G, Armstrong PW, Tricoci P, Gibson CM, Califf RM, Harrington RA, Newby LK. Routine early eptifibatide versus delayed provisional use at percutaneous coronary intervention in high-risk non-ST-segment elevation acute coronary syndromes patients: an analysis from the Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome trial. Am Heart J. 2013 Sep;166(3):466-73. doi: 10.1016/j.ahj.2013.05.019. Epub 2013 Jul 25.
Hess CN, Rao SV, Kong DF, Aberle LH, Anstrom KJ, Gibson CM, Gilchrist IC, Jacobs AK, Jolly SS, Mehran R, Messenger JC, Newby LK, Waksman R, Krucoff MW. Embedding a randomized clinical trial into an ongoing registry infrastructure: unique opportunities for efficiency in design of the Study of Access site For Enhancement of Percutaneous Coronary Intervention for Women (SAFE-PCI for Women). Am Heart J. 2013 Sep;166(3):421-8. doi: 10.1016/j.ahj.2013.06.013. Epub 2013 Jul 23.
Grayburn PA, Foster E, Sangli C, Weissman NJ, Massaro J, Glower DG, Feldman T, Mauri L. Relationship between the magnitude of reduction in mitral regurgitation severity and left ventricular and left atrial reverse remodeling after MitraClip therapy. Circulation. 2013 Oct 8;128(15):1667-74. doi: 10.1161/CIRCULATIONAHA.112.001039. Epub 2013 Sep 6.
Steg PG, Bhatt DL, Hamm CW, Stone GW, Gibson CM, Mahaffey KW, Leonardi S, Liu T, Skerjanec S, Day JR, Iwaoka RS, Stuckey TD, Gogia HS, Gruberg L, French WJ, White HD, Harrington RA; CHAMPION Investigators. Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data. Lancet. 2013 Dec 14;382(9909):1981-92. doi: 10.1016/S0140-6736(13)61615-3. Epub 2013 Sep 3.
Mehran R, Baber U, Steg PG, Ariti C, Weisz G, Witzenbichler B, Henry TD, Kini AS, Stuckey T, Cohen DJ, Berger PB, Iakovou I, Dangas G, Waksman R, Antoniucci D, Sartori S, Krucoff MW, Hermiller JB, Shawl F, Gibson CM, Chieffo A, Alu M, Moliterno DJ, Colombo A, Pocock S. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet. 2013 Nov 23;382(9906):1714-22. doi: 10.1016/S0140-6736(13)61720-1. Epub 2013 Sep 1.
Ho JE, Chen WY, Chen MH, Larson MG, McCabe EL, Cheng S, Ghorbani A, Coglianese E, Emilsson V, Johnson AD, Walter S, Franceschini N, O’Donnell CJ; CARDIoGRAM Consortium; CHARGE Inflammation Working Group, Dehghan A, Lu C, Levy D, Newton-Cheh C; CHARGE Heart Failure Working Group, Lin H, Felix JF, Schreiter ER, Vasan RS, Januzzi JL, Lee RT, Wang TJ. Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling. J Clin Invest. 2013 Oct;123(10):4208-18. doi: 10.1172/JCI67119. Epub 2013 Sep 3.
Paton A, Stein DE, D’Agostino R, Pastores SM, Halpern NA. Critical care medicine advanced practice provider model at a comprehensive cancer center: successes and challenges. Am J Crit Care. 2013 Sep;22(5):439-43. doi: 10.4037/ajcc2013821.
White WB, Cannon CP, Heller SR, Nissen SE, Bergenstal RM, Bakris GL, Perez AT, Fleck PR, Mehta CR, Kupfer S, Wilson C, Cushman WC, Zannad F; EXAMINE Investigators. Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med. 2013 Oct 3;369(14):1327-35. doi: 10.1056/NEJMoa1305889. Epub 2013 Sep 2.
Lauer MS, D’Agostino RB Sr. The randomized registry trial–the next disruptive technology in clinical research?. N Engl J Med. 2013 Oct 24;369(17):1579-81. doi: 10.1056/NEJMp1310102. Epub 2013 Aug 31.
Cannon CP. Should we measure quality by the dose?. J Am Coll Cardiol. 2013 Nov 5;62(19):1802-3. doi: 10.1016/j.jacc.2013.07.059. Epub 2013 Aug 21.
Rosenquist KJ, Massaro JM, Pencina KM, D’Agostino RB, Beiser A, O’Connor GT, O’Donnell CJ, Wolf PA, Polak JF, Seshadri S, Fox CS. Neck circumference, carotid wall intima-media thickness, and incident stroke. Diabetes Care. 2013 Sep;36(9):e153-4. doi: 10.2337/dc13-0379.
Vardi M, Yeh RW, Herzog CA, Winkelmayer WC, Setoguchi S, Charytan DM. Strategies for postmarketing surveillance of drugs and devices in patients with ESRD undergoing dialysis. Clin J Am Soc Nephrol. 2013 Dec;8(12):2213-20. doi: 10.2215/CJN.05130513. Epub 2013 Aug 22.
Brennan JM, Curtis JP, Dai D, Fitzgerald S, Khandelwal AK, Spertus JA, Rao SV, Singh M, Shaw RE, Ho KK, Krone RJ, Weintraub WS, Weaver WD, Peterson ED; National Cardiovascular Data Registry. Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: results from 1,208,137 procedures in the NCDR (National Cardiovascular Data Registry). JACC Cardiovasc Interv. 2013 Aug;6(8):790-9. doi: 10.1016/j.jcin.2013.03.020.
Wimmer NJ, Resnic FS, Mauri L, Matheny ME, Yeh RW. Comparison of transradial versus transfemoral percutaneous coronary intervention in routine practice: evidence for the importance of “falsification hypotheses” in observational studies of comparative effectiveness. J Am Coll Cardiol. 2013 Dec 3;62(22):2147-8. doi: 10.1016/j.jacc.2013.07.036. Epub 2013 Aug 14.
Bajwa EK, Volk JA, Christiani DC, Harris RS, Matthay MA, Thompson BT, Januzzi JL; National Heart, Lung and Blood Institute Acute Respiratory Distress Syndrome Network. Prognostic and diagnostic value of plasma soluble suppression of tumorigenicity-2 concentrations in acute respiratory distress syndrome. Crit Care Med. 2013 Nov;41(11):2521-31. doi: 10.1097/CCM.0b013e3182978f91.
Reynolds MR, Floyd RG, Niileksela CR. How well is psychometric g indexed by global composites? Evidence from three popular intelligence tests. Psychol Assess. 2013 Dec;25(4):1314-21. doi: 10.1037/a0034102. Epub 2013 Aug 12.
Toh S, Avorn J, D’Agostino RB Sr, Gurwitz JH, Psaty BM, Rothman KJ, Saag KG, Sturkenboom MC, Vandenbroucke JP, Winterstein AG, Strom BL. Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs. Pharmacoepidemiol Drug Saf. 2013 Oct;22(10):1036-45. doi: 10.1002/pds.3478. Epub 2013 Aug 7.
Yonetsu T, Kato K, Uemura S, Kim BK, Jang Y, Kang SJ, Park SJ, Lee S, Kim SJ, Jia H, Vergallo R, Abtahian F, Tian J, Hu S, Yeh RW, Sakhuja R, McNulty I, Lee H, Zhang S, Yu B, Kakuta T, Jang IK. Features of coronary plaque in patients with metabolic syndrome and diabetes mellitus assessed by 3-vessel optical coherence tomography. Circ Cardiovasc Imaging. 2013 Sep;6(5):665-73. doi: 10.1161/CIRCIMAGING.113.000345. Epub 2013 Aug 6.
Manzano-Fernández S, Flores-Blanco PJ, Pérez-Calvo JI, Ruiz-Ruiz FJ, Carrasco-Sánchez FJ, Morales-Rull JL, Galisteo-Almeda L, Pascual-Figal D, Valdes M, Januzzi JL. Comparison of risk prediction with the CKD-EPI and MDRD equations in acute decompensated heart failure. J Card Fail. 2013 Aug;19(8):583-91. doi: 10.1016/j.cardfail.2013.05.011.
De Luca G, van’t Hof AW, Huber K, Gibson CM, Bellandi F, Arntz HR, Maioli M, Noc M, Zorman S, Zeymer U, Gabriel HM, Emre A, Cutlip D, Rakowski T, Gyongyosi M, Dudek D; EGYPT cooperation. Impact of hypertension on distal embolization, myocardial perfusion, and mortality in patients with ST segment elevation myocardial infarction undergoing primary angioplasty. Am J Cardiol. 2013 Oct 15;112(8):1083-6. doi: 10.1016/j.amjcard.2013.05.053. Epub 2013 Aug 1.
Reynolds MR, Grubb RL Jr, Clarke WR, Powers WJ, Zipfel GJ, Adams HP Jr, Derdeyn CP; Carotid Occlusion Surgery Study Investigators. Investigating the mechanisms of perioperative ischemic stroke in the Carotid Occlusion Surgery Study. J Neurosurg. 2013 Oct;119(4):988-95. doi: 10.3171/2013.6.JNS13312. Epub 2013 Aug 2.
Murphy TP, Reynolds MR, Cohen DJ, Regensteiner JG, Massaro JM, Cutlip DE, Mohler ER, Cerezo J, Oldenburg NC, Thum CC, Goldberg S, Hirsch AT. Correlation of patient-reported symptom outcomes and treadmill test outcomes after treatment for aortoiliac claudication. J Vasc Interv Radiol. 2013 Oct;24(10):1427-35; quiz 1436. doi: 10.1016/j.jvir.2013.05.057. Epub 2013 Jul 29.
Dorian P, Burk C, Mullin CM, Bubien R, Godejohn D, Reynolds MR, Lakkireddy DR, Wimmer AP, Bhandari A, Spertus J. Interpreting changes in quality of life in atrial fibrillation: how much change is meaningful?. Am Heart J. 2013 Aug;166(2):381-387.e8. doi: 10.1016/j.ahj.2013.04.015. Epub 2013 Jul 1.
Peacock WF, Kontos MC, Amsterdam E, Cannon CP, Diercks D, Garvey L, Graff L 4th, Holmes D, Holmes KS, McCord J, Newby K, Roe M, Dadkhah S, Siler-Fisher A, Ross M. Impact of Society of Cardiovascular Patient Care accreditation on quality: an ACTION Registry®-Get With The Guidelines™ analysis. Crit Pathw Cardiol. 2013 Sep;12(3):116-20. doi: 10.1097/HPC.0b013e31828940e3.
Reynolds MR, Ingram PB, Seeley JS, Newby KD. Investigating the structure and invariance of the Wechsler Adult Intelligence Scales, Fourth Edition in a sample of adults with intellectual disabilities. Res Dev Disabil. 2013 Oct;34(10):3235-45. doi: 10.1016/j.ridd.2013.06.029. Epub 2013 Jul 24.
Booher AM, Isselbacher EM, Nienaber CA, Trimarchi S, Evangelista A, Montgomery DG, Froehlich JB, Ehrlich MP, Oh JK, Januzzi JL, O’Gara P, Sundt TM, Harris KM, Bossone E, Pyeritz RE, Eagle KA; IRAD Investigators. The IRAD classification system for characterizing survival after aortic dissection. Am J Med. 2013 Aug;126(8):730.e19-24. doi: 10.1016/j.amjmed.2013.01.020.
Delaney JA, Lehmann N, Jöckel KH, Elmariah S, Psaty BM, Mahabadi AA, Budoff M, Kronmal RA, Nasir K, O’Brien KD, Möhlenkamp S, Moebus S, Dragano N, Winterstein AG, Erbel R, Kälsch H. Associations between aspirin and other non-steroidal anti-inflammatory drugs and aortic valve or coronary artery calcification: the Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall Study. Atherosclerosis. 2013 Aug;229(2):310-6. doi: 10.1016/j.atherosclerosis.2013.05.002. Epub 2013 May 14.
Ho JE, Hwang SJ, Wollert KC, Larson MG, Cheng S, Kempf T, Vasan RS, Januzzi JL, Wang TJ, Fox CS. Biomarkers of cardiovascular stress and incident chronic kidney disease. Clin Chem. 2013 Nov;59(11):1613-20. doi: 10.1373/clinchem.2013.205716. Epub 2013 Jul 19.
Amin AP, House JA, Safley DM, Chhatriwalla AK, Giersiefen H, Bremer A, Hamon M, Baklanov DV, Aluko A, Wohns D, Mathias DW, Applegate RA, Cohen DJ, Marso SP. Costs of transradial percutaneous coronary intervention. JACC Cardiovasc Interv. 2013 Aug;6(8):827-34. doi: 10.1016/j.jcin.2013.04.014. Epub 2013 Jul 17.
Reynolds MR, Keith TZ, Flanagan DP, Alfonso VC. A cross-battery, reference variable, confirmatory factor analytic investigation of the CHC taxonomy. J Sch Psychol. 2013 Aug;51(4):535-55. doi: 10.1016/j.jsp.2013.02.003. Epub 2013 Mar 22.
Brener SJ, Maehara A, Dizon JM, Fahy M, Witzenbichler B, Parise H, El-Omar M, Dambrink JH, Mehran R, Oldroyd K, Gibson CM, Stone GW. Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial. JACC Cardiovasc Interv. 2013 Jul;6(7):718-24. doi: 10.1016/j.jcin.2013.03.013.
Kunadian V, James SK, Wojdyla DM, Zorkun C, Wu J, Storey RF, Steg PG, Katus H, Emanuelsson H, Horrow J, Maya J, Wallentin L, Harrington RA, Gibson CM. Angiographic outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes). JACC Cardiovasc Interv. 2013 Jul;6(7):671-83. doi: 10.1016/j.jcin.2013.03.014.
Januzzi JL. Letter by Januzzi regarding article, “galectin-3 and cardiac function in survivors of acute myocardial infarction”. Circ Heart Fail. 2013 Jul;6(4):e57. doi: 10.1161/CIRCHEARTFAILURE.113.000375.
Peberdy MA, Donnino MW, Callaway CW, Dimaio JM, Geocadin RG, Ghaemmaghami CA, Jacobs AK, Kern KB, Levy JH, Link MS, Menon V, Ornato JP, Pinto DS, Sugarman J, Yannopoulos D, Ferguson TB Jr; American Heart Association Emergency Cardiovascular Care Committee; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation. Impact of percutaneous coronary intervention performance reporting on cardiac resuscitation centers: a scientific statement from the American Heart Association. Circulation. 2013 Aug 13;128(7):762-73. doi: 10.1161/CIR.0b013e3182a15cd2. Epub 2013 Jul 15.
King G, Wood MJ. The heart of the endurance athlete assessed by echocardiography and its modalities: “embracing the delicate balance”. Curr Cardiol Rep. 2013 Aug;15(8):383. doi: 10.1007/s11886-013-0383-1.
Reynolds MR, Cohen DJ. The cost-effectiveness of transcatheter aortic valve replacement for nonsurgical candidates: revisionist history or the final word?. Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):376-8. doi: 10.1161/CIRCOUTCOMES.113.000330. Epub 2013 Jul 9.
Spertus JA, Maron DJ, Cohen DJ, Kolm P, Hartigan P, Weintraub WS, Berman DS, Teo KK, Shaw LJ, Sedlis SP, Knudtson M, Aslan M, Dada M, Boden WE, Mancini GB; Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Investigators and Coordinators. Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial. Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):409-18. doi: 10.1161/CIRCOUTCOMES.113.000139. Epub 2013 Jul 9.
Piccini JP, White JA, Mehta RH, Lokhnygina Y, Al-Khatib SM, Tricoci P, Califf RM, Harrington RA, Newby LK, Pollack CV Jr, Montalescot G, Van de Werf F, Gibson CM, Giugliano RP. Response to letter regarding article, “sustained ventricular tachycardia and ventricular fibrillation complicating non–ST-segment elevation acute coronary syndromes”. Circulation. 2013 May 21;127(20):e634. doi: 10.1161/circulationaha.112.147546.
Legrand M, Januzzi JL Jr, Mebazaa A. Critical research on biomarkers: what’s new?. Intensive Care Med. 2013 Oct;39(10):1824-8. doi: 10.1007/s00134-013-3008-7. Epub 2013 Jul 5.
Gershoni-Poranne R, Gibson CM, Fowler PW, Stanger A. Concurrence between current density, nucleus-independent chemical shifts, and aromatic stabilization energy: the case of isomeric [4]- and [5]phenylenes. J Org Chem. 2013 Aug 2;78(15):7544-53. doi: 10.1021/jo4011014. Epub 2013 Jul 22.
Wasfy JH, Rosenfield K, Zelevinsky K, Sakhuja R, Lovett A, Spertus JA, Wimmer NJ, Mauri L, Normand SL, Yeh RW. A prediction model to identify patients at high risk for 30-day readmission after percutaneous coronary intervention. Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):429-35. doi: 10.1161/CIRCOUTCOMES.111.000093. Epub 2013 Jul 2.
Zhang H, Plutzky J, Turchin A. Discontinuation of statins in routine care settings. Ann Intern Med. 2013 Jul 2;159(1):75-6. doi: 10.7326/0003-4819-159-1-201307020-00022.
Larsen M, Bartnes K, Tsai TT, Eagle KA, Evangelista A, Nienaber CA, Suzuki T, Fattori R, Froehlich JB, Hutchison S, Sundt TM, Januzzi JL, Isselbacher EM, Montgomery DG, Myrmel T. Extent of preoperative false lumen thrombosis does not influence long-term survival in patients with acute type A aortic dissection. J Am Heart Assoc. 2013 Jul 1;2(4):e000112. doi: 10.1161/JAHA.113.000112.
Brener SJ, Witzenbichler B, Maehara A, Dizon J, Fahy M, El-Omar M, Dambrink JH, Genereux P, Mehran R, Oldroyd K, Parise H, Gibson CM, Stone GW. Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: the Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction (INFUSE-AMI) trial. Am Heart J. 2013 Jul;166(1):64-70. doi: 10.1016/j.ahj.2013.03.029. Epub 2013 Apr 30.
Kumbhani DJ, Steg PG, Cannon CP, Eagle KA, Smith SC Jr, Hoffman E, Goto S, Ohman EM, Bhatt DL; REduction of Atherothrombosis for Continued Health Registry Investigators. Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis. Am J Med. 2013 Aug;126(8):693-700.e1. doi: 10.1016/j.amjmed.2013.01.033. Epub 2013 Jun 22.
James SK, Storey RF, Pieper KS, Cannon CP, Becker RC, Steg PG, Wallentin L, Harrington RA; PLATO Study Group. Response to letter regarding article, “Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials”. Stroke. 2013 Aug;44(8):e95-6. doi: 10.1161/STROKEAHA.113.002069. Epub 2013 Jun 25.
Yeh RW, Drachman DE. Coronary chronic total occlusion in the elderly: demographic inevitability, treatment uncertainty. Catheter Cardiovasc Interv. 2013 Jul 1;82(1):93-4. doi: 10.1002/ccd.25013.
Terkelsen CJ, Pinto DS, Thiele H, Clemmensen P, Nikus K, Lassen JF, Hildick-Smith D, Christiansen EH, Aarøe J, Hansen HH, Stankovic G, Junker A, Sianos G, Olivecrona G, Bøtker HE, Gibson CM, Boersma E. 2012 ESC STEMI guidelines and reperfusion therapy: Evidence base ignored, threatening optimal patient management. Heart. 2013 Aug;99(16):1154-6. doi: 10.1136/heartjnl-2013-304117. Epub 2013 Jun 17.
Kuntz RE. The changing structure of industry-sponsored clinical research: pioneering data sharing and transparency. Ann Intern Med. 2013 Jun 18;158(12):914-5. doi: 10.7326/0003-4819-158-12-201306180-00011.
Brener SJ, Dambrink JH, Maehara A, Chowdhary S, Gershlick AH, Genereux P, Koolen J, Mehran R, Fahy M, Gibson CM, Stone GW. Benefits of optimising coronary flow before stenting in primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from INFUSE-AMI. EuroIntervention. 2013 Jun 14:20130401-06. Online ahead of print.
Celano CM, Suarez L, Mastromauro C, Januzzi JL, Huffman JC. Feasibility and utility of screening for depression and anxiety disorders in patients with cardiovascular disease. Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):498-504. doi: 10.1161/CIRCOUTCOMES.111.000049. Epub 2013 Jun 11.
Kramer DB, Kennedy KF, Noseworthy PA, Buxton AE, Josephson ME, Normand SL, Spertus JA, Zimetbaum PJ, Reynolds MR, Mitchell SL. Characteristics and outcomes of patients receiving new and replacement implantable cardioverter-defibrillators: results from the NCDR. Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):488-97. doi: 10.1161/CIRCOUTCOMES.111.000054. Epub 2013 Jun 11.
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239. doi: 10.1016/j.jacc.2013.05.019. Epub 2013 Jun 5.
WRITING COMMITTEE MEMBERS, Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013 Oct 15;128(16):e240-327. doi: 10.1161/CIR.0b013e31829e8776. Epub 2013 Jun 5.
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013 Oct 15;128(16):1810-52. doi: 10.1161/CIR.0b013e31829e8807. Epub 2013 Jun 5.
Vardi M, Burke DA, Bangalore S, Pencina MJ, Mauri L, Kandzari DE, Leon MB, Cutlip DE. Long-term efficacy and safety of Zotarolimus-eluting stent in patients with diabetes mellitus: pooled 5-year results from the ENDEAVOR III and IV trials. Catheter Cardiovasc Interv. 2013 Dec 1;82(7):1031-8. doi: 10.1002/ccd.25045. Epub 2013 Jul 4.
Weiner RB, Wood MJ, Pellikka PA. Repeated testing and appropriate use of echocardiography. JAMA Intern Med. 2013 May 27;173(10):935. doi: 10.1001/jamainternmed.2013.395.
Mega JL, Braunwald E, Wiviott SD, Murphy SA, Plotnikov A, Gotcheva N, Ruda M, Gibson CM. Comparison of the efficacy and safety of two rivaroxaban doses in acute coronary syndrome (from ATLAS ACS 2-TIMI 51). Am J Cardiol. 2013 Aug 15;112(4):472-8. doi: 10.1016/j.amjcard.2013.04.011. Epub 2013 May 24.
Wimmer NJ, Resnic FS, Mauri L, Matheny ME, Piemonte TC, Pomerantsev E, Ho KK, Robbins SL, Waldman HM, Yeh RW. Risk-treatment paradox in the selection of transradial access for percutaneous coronary intervention. J Am Heart Assoc. 2013 May 24;2(3):e000174. doi: 10.1161/JAHA.113.000174.
López-Cuenca Á, Manzano-Fernández S, Marín F, Parra-Pallares S, Navarro-Peñalver M, Montalban-Larrea S, Andreu-Cayuelas JM, Romero-Aniorte AI, Avilés-Plaza F, Valdés-Chavarri M, Januzzi JL Jr. Beta-trace protein and cystatin c as predictors of major bleeding in non-ST-segment elevation acute coronary syndrome. Circ J. 2013;77(8):2088-96. doi: 10.1253/circj.cj-13-0106. Epub 2013 May 23.
Jasuja GK, Travison TG, Davda M, Rose AJ, Zhang A, Kushnir MM, Rockwood AL, Meikle W, Coviello AD, D’Agostino R, Vasan RS, Bhasin S. Circulating estrone levels are associated prospectively with diabetes risk in men of the Framingham Heart Study. Diabetes Care. 2013 Sep;36(9):2591-6. doi: 10.2337/dc12-2477. Epub 2013 May 20.
Rhee EP, Clish CB, Ghorbani A, Larson MG, Elmariah S, McCabe E, Yang Q, Cheng S, Pierce K, Deik A, Souza AL, Farrell L, Domos C, Yeh RW, Palacios I, Rosenfield K, Vasan RS, Florez JC, Wang TJ, Fox CS, Gerszten RE. A combined epidemiologic and metabolomic approach improves CKD prediction. J Am Soc Nephrol. 2013 Jul;24(8):1330-8. doi: 10.1681/ASN.2012101006. Epub 2013 May 16.
Tricoci P, Leonardi S, White J, White HD, Armstrong PW, Montalescot G, Giugliano RP, Gibson CM, Van de Werf F, Califf RM, Harrington RA, Braunwald E, Mahaffey KW, Newby LK. Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends. J Am Coll Cardiol. 2013 Jul 16;62(3):242-251. doi: 10.1016/j.jacc.2013.04.043. Epub 2013 May 15.
Popma JJ, Reardon MJ. North American view on the European Sentinel Registry of the Transcatheter Valve Implantation pilot study. EuroIntervention. 2013 Apr 22;8(12):1353, 1355. doi: 10.4244/EIJV8I12A206.
Cannon CP, Brindis RG, Chaitman BR, Cohen DJ, Cross JT Jr, Drozda JP Jr, Fesmire FM, Fintel DJ, Fonarow GC, Fox KA, Gray DT, Harrington RA, Hicks KA, Hollander JE, Krumholz H, Labarthe DR, Long JB, Mascette AM, Meyer C, Peterson ED, Radford MJ, Roe MT, Richmann JB, Selker HP, Shahian DM, Shaw RE, Sprenger S, Swor R, Underberg JA, Van de Werf F, Weiner BH, Weintraub WS. 2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Acute Coronary Syndromes and Coronary Artery Disease Clinical Data Standards). Crit Pathw Cardiol. 2013 Jun;12(2):65-105. doi: 10.1097/HPC.0b013e3182846e16.
Motiwala SR, Szymonifka J, Belcher A, Weiner RB, Baggish AL, Sluss P, Gaggin HK, Bhardwaj A, Januzzi JL. Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study. Eur J Heart Fail. 2013 Oct;15(10):1157-63. doi: 10.1093/eurjhf/hft075. Epub 2013 May 10.
Kelly NP, Januzzi JL Jr. The role of B-type natriuretic Peptide testing in guiding outpatient heart failure treatment. Curr Treat Options Cardiovasc Med. 2013 Aug;15(4):397-409. doi: 10.1007/s11936-013-0247-4.
Pinto DS, Pride YB. Paved with good intentions and marred by half-truths. J Am Coll Cardiol. 2013 Jul 30;62(5):416-7. doi: 10.1016/j.jacc.2013.04.026. Epub 2013 May 9.
Mauri L, Foster E, Glower DD, Apruzzese P, Massaro JM, Herrmann HC, Hermiller J, Gray W, Wang A, Pedersen WR, Bajwa T, Lasala J, Low R, Grayburn P, Feldman T; EVEREST II Investigators. 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. J Am Coll Cardiol. 2013 Jul 23;62(4):317-28. doi: 10.1016/j.jacc.2013.04.030. Epub 2013 May 9.
Januzzi JL Jr. Natriuretic peptides as biomarkers in heart failure. J Investig Med. 2013 Aug;61(6):950-5. doi: 10.2310/JIM.0b013e3182946b69.
Huffman JC, Celano CM, Beach SR, Motiwala SR, Januzzi JL. Depression and cardiac disease: epidemiology, mechanisms, and diagnosis. Cardiovasc Psychiatry Neurol. 2013;2013:695925. doi: 10.1155/2013/695925. Epub 2013 Apr 7.
Lauerman MH, Rybin D, Doros G, Kalish J, Hamburg N, Eberhardt RT, Farber A. Characterization and outcomes of iliac vessel injury in the 21st century: a review of the National Trauma Data Bank. Vasc Endovascular Surg. 2013 Jul;47(5):325-30. doi: 10.1177/1538574413487260. Epub 2013 May 6.
Olivotto I, Maron BJ, Tomberli B, Appelbaum E, Salton C, Haas TS, Gibson CM, Nistri S, Servettini E, Chan RH, Udelson JE, Lesser JR, Cecchi F, Manning WJ, Maron MS. Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2013 Jul 30;62(5):449-57. doi: 10.1016/j.jacc.2013.03.062. Epub 2013 Apr 30.
Drafts BC, Twomley KM, D’Agostino R Jr, Lawrence J, Avis N, Ellis LR, Thohan V, Jordan J, Melin SA, Torti FM, Little WC, Hamilton CA, Hundley WG. Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease. JACC Cardiovasc Imaging. 2013 Aug;6(8):877-85. doi: 10.1016/j.jcmg.2012.11.017. Epub 2013 May 1.
Demler OV, Pencina MJ, D’Agostino RB Sr. Impact of correlation on predictive ability of biomarkers. Stat Med. 2013 Oct 30;32(24):4196-210. doi: 10.1002/sim.5824. Epub 2013 May 3.
Fein AS, Shvilkin A, Shah D, Haffajee CI, Das S, Kumar K, Kramer DB, Zimetbaum PJ, Buxton AE, Josephson ME, Anter E. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol. 2013 Jul 23;62(4):300-5. doi: 10.1016/j.jacc.2013.03.052. Epub 2013 Apr 23.
Ho JE, Larson MG, Ghorbani A, Cheng S, Vasan RS, Wang TJ, Januzzi JL Jr. Soluble ST2 predicts elevated SBP in the community. J Hypertens. 2013 Jul;31(7):1431-6; discussion 1436. doi: 10.1097/HJH.0b013e3283611bdf.
Gibson CM, Chakrabarti AK, Mega J, Bode C, Bassand JP, Verheugt FW, Bhatt DL, Goto S, Cohen M, Mohanavelu S, Burton P, Stone G, Braunwald E; ATLAS-ACS 2 TIMI 51 Investigators. Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51. J Am Coll Cardiol. 2013 Jul 23;62(4):286-90. doi: 10.1016/j.jacc.2013.03.041. Epub 2013 Apr 16.
Buyukkaya E, Poyraz F, Karakas MF, Kurt M, Akcay AB, Akpinar I, Motor S, Turak O, Ozturk OH, Sen N, Akpek M, Kaya MG, Gibson CM. Usefulness of monocyte chemoattractant protein-1 to predict no-reflow and three-year mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol. 2013 Jul 15;112(2):187-93. doi: 10.1016/j.amjcard.2013.03.011. Epub 2013 Apr 18.
Chevalier B, Dimario C, Neumann FJ, Cutlip DE, Williams DO, Ormiston J, Grube E, Whitbourn R, Coe J, Schwartz LB; ZOMAXX I Investigators. A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus- vs. Paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries: five-year results from the ZOMAXX I trial. Catheter Cardiovasc Interv. 2013 Dec 1;82(7):1039-47. doi: 10.1002/ccd.24958. Epub 2013 Jul 25.
Margheri G, D’Agostino R, Del Rosso M, Trigari S. Fabrication of GM3-enriched sphingomyelin/cholesterol solid-supported lipid membranes on Au/SiO2 plasmonic substrates. Lipids. 2013 Jul;48(7):739-47. doi: 10.1007/s11745-013-3789-z. Epub 2013 Apr 17.
Kramer DB, Reynolds MR, Mitchell SL. Resynchronization: considering device-based cardiac therapy in older adults. J Am Geriatr Soc. 2013 Apr;61(4):615-21. doi: 10.1111/jgs.12174. Epub 2013 Mar 21.
James SK, Pieper KS, Cannon CP, Storey RF, Becker RC, Steg PG, Wallentin L, Harrington RA; PLATO study group. Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials. Stroke. 2013 May;44(5):1477-9. doi: 10.1161/STROKEAHA.111.000514. Epub 2013 Apr 9.
Mauer AC, Baron SJ, Yeh RW, Scott NS. Caesarian dissection: a case of chest pain and dyspnea during delivery. Circulation. 2013 Apr 9;127(14):1530-5. doi: 10.1161/CIRCULATIONAHA.112.000858.
Bainey KR, Natarajan MK, Mercuri M, Lai T, Teoh K, Chu V, Whitlock RP, Velianou JL. Treatment assignment of high-risk symptomatic severe aortic stenosis patients referred for transcatheter AorticValve implantation. Am J Cardiol. 2013 Jul 1;112(1):100-3. doi: 10.1016/j.amjcard.2013.02.062. Epub 2013 Apr 2.
Januzzi JL Jr. ST2 as a cardiovascular risk biomarker: from the bench to the bedside. J Cardiovasc Transl Res. 2013 Aug;6(4):493-500. doi: 10.1007/s12265-013-9459-y. Epub 2013 Apr 5.
Januzzi JL, Horne BD, Moore SA, Galenko O, Snow GL, Brunisholz KD, Muhlestein JB, Alharethi R, Carlquist JF, Budge D, Rasmussen K, Kfoury AG. Interleukin receptor family member ST2 concentrations in patients following heart transplantation. Biomarkers. 2013 May;18(3):250-6. doi: 10.3109/1354750X.2013.773081. Epub 2013 Apr 5.
Sperandio FF, Giudice FS, Corrêa L, Pinto DS Jr, Hamblin MR, de Sousa SC. Low-level laser therapy can produce increased aggressiveness of dysplastic and oral cancer cell lines by modulation of Akt/mTOR signaling pathway. J Biophotonics. 2013 Oct;6(10):839-47. doi: 10.1002/jbio.201300015. Epub 2013 Apr 2.
Nigwekar SU, Bhan I, Turchin A, Skentzos SC, Hajhosseiny R, Steele D, Nazarian RM, Wenger J, Parikh S, Karumanchi A, Thadhani R. Statin use and calcific uremic arteriolopathy: a matched case-control study. Am J Nephrol. 2013;37(4):325-32. doi: 10.1159/000348806. Epub 2013 Mar 21.
Zhang H, Plutzky J, Skentzos S, Morrison F, Mar P, Shubina M, Turchin A. Discontinuation of statins in routine care settings: a cohort study. Ann Intern Med. 2013 Apr 2;158(7):526-34. doi: 10.7326/0003-4819-158-7-201304020-00004.
Williams JB, Lopes RD, Hafley GE, Ferguson TB Jr, Mack MJ, Gibson CM, Harrington RA, Peterson ED, Smith PK, Mehta RH, Alexander JH. Relationship between postoperative clopidogrel use and subsequent angiographic and clinical outcomes following coronary artery bypass grafting. J Thromb Thrombolysis. 2013 Nov;36(4):384-93. doi: 10.1007/s11239-013-0904-1.
Guay AT, Traish AM, Hislop-Chestnut DT, Doros G, Gawoski JM. Are there variances of calculated free testosterone attributed to variations in albumin and sex hormone-binding globulin concentrations in men?. Endocr Pract. 2013 Mar-Apr;19(2):236-42. doi: 10.4158/EP12113.OR.
Amin AP, Bachuwar A, Reid KJ, Chhatriwalla AK, Salisbury AC, Yeh RW, Kosiborod M, Wang TY, Alexander KP, Gosch K, Cohen DJ, Spertus JA, Bach RG. Nuisance bleeding with prolonged dual antiplatelet therapy after acute myocardial infarction and its impact on health status. J Am Coll Cardiol. 2013 May 28;61(21):2130-8. doi: 10.1016/j.jacc.2013.02.044. Epub 2013 Mar 26.
Lassus J, Gayat E, Mueller C, Peacock WF, Spinar J, Harjola VP, van Kimmenade R, Pathak A, Mueller T, Disomma S, Metra M, Pascual-Figal D, Laribi S, Logeart D, Nouira S, Sato N, Potocki M, Parenica J, Collet C, Cohen-Solal A, Januzzi JL Jr, Mebazaa A; GREAT-Network. Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study. Int J Cardiol. 2013 Oct 3;168(3):2186-94. doi: 10.1016/j.ijcard.2013.01.228. Epub 2013 Mar 26.
Klutstein MW, Westerhout CM, Armstrong PW, Giugliano RP, Lewis BS, Gibson CM, Lutchmedial S, Widimsky P, Steg PG, Dalby A, Zeymer U, Van de Werf F, Harrington RA, Newby LK, Rao SV. Radial versus femoral access, bleeding and ischemic events in patients with non-ST-segment elevation acute coronary syndrome managed with an invasive strategy. Am Heart J. 2013 Apr;165(4):583-590.e1. doi: 10.1016/j.ahj.2013.01.009. Epub 2013 Feb 22.
Chakrabarti AK, Feeney K, Abueg C, Brown DA, Czyz E, Tendera M, Janosi A, Giugliano RP, Kloner RA, Weaver WD, Bode C, Godlewski J, Merkely B, Gibson CM. Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction. Am Heart J. 2013 Apr;165(4):509-514.e7. doi: 10.1016/j.ahj.2012.12.008. Epub 2013 Feb 15.
Goel K, Pinto DS, Gibson CM. Association of time to reperfusion with left ventricular function and heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: a systematic review. Am Heart J. 2013 Apr;165(4):451-67. doi: 10.1016/j.ahj.2012.11.014. Epub 2013 Feb 14.
Tanaka K, Essick EE, Doros G, Tanriverdi K, Connors LH, Seldin DC, Sam F. Circulating matrix metalloproteinases and tissue inhibitors of metalloproteinases in cardiac amyloidosis. J Am Heart Assoc. 2013 Mar 12;2(2):e005868. doi: 10.1161/JAHA.112.005868.
Tan TW, Farber A, Hamburg NM, Eberhardt RT, Rybin D, Doros G, Eldrup-Jorgensen J, Goodney PP, Cronenwett JL, Kalish JA; Vascular Study Group of New England. Blood transfusion for lower extremity bypass is associated with increased wound infection and graft thrombosis. J Am Coll Surg. 2013 May;216(5):1005-1014.e2; quiz 1031-3. doi: 10.1016/j.jamcollsurg.2013.01.006. Epub 2013 Mar 25.
Mehrotra P, Jansen K, Flynn AW, Tan TC, Elmariah S, Picard MH, Hung J. Differential left ventricular remodelling and longitudinal function distinguishes low flow from normal-flow preserved ejection fraction low-gradient severe aortic stenosis. Eur Heart J. 2013 Jul;34(25):1906-14. doi: 10.1093/eurheartj/eht094. Epub 2013 Mar 26.
Wayangankar SA, Abu-Fadel MS, Aronow HD, Kennedy KF, Gupta R, Yeh RW, Gray WA, Rosenfield K, Hennebry TA. Hemorrhagic and ischemic outcomes after bivalirudin versus unfractionated heparin during carotid artery stenting: a propensity score analysis from the NCDR. Circ Cardiovasc Interv. 2013 Apr;6(2):131-8. doi: 10.1161/CIRCINTERVENTIONS.112.974857. Epub 2013 Mar 26.
Güngör D, Kruijshaar ME, Plug I, D’Agostino RB, Hagemans ML, van Doorn PA, Reuser AJ, van der Ploeg AT. Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study. Orphanet J Rare Dis. 2013 Mar 27;8:49. doi: 10.1186/1750-1172-8-49.
Giudice FS, Pinto DS Jr, Nör JE, Squarize CH, Castilho RM. Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancer. PLoS One. 2013;8(3):e58672. doi: 10.1371/journal.pone.0058672. Epub 2013 Mar 20.
Matthan NR, Zhu L, Pencina M, D’Agostino RB, Schaefer EJ, Lichtenstein AH. Sex-specific differences in the predictive value of cholesterol homeostasis markers and 10-year cardiovascular disease event rate in Framingham Offspring Study participants. J Am Heart Assoc. 2013 Feb 19;2(1):e005066. doi: 10.1161/JAHA.112.005066.
Kirtane AJ, Leon MB, Ball MW, Bajwa HS, Sketch MH Jr, Coleman PS, Stoler RC, Papadakos S, Cutlip DE, Mauri L, Kandzari DE; ENDEAVOR IV Investigators. The “final” 5-year follow-up from the ENDEAVOR IV trial comparing a zotarolimus-eluting stent with a paclitaxel-eluting stent. JACC Cardiovasc Interv. 2013 Apr;6(4):325-33. doi: 10.1016/j.jcin.2012.12.123. Epub 2013 Mar 20.
Mogabgab O, Wiviott SD, Antman EM, Foody JM, Wang TY, Sabatine MS, Cannon CP, Li S, Giugliano RP. Relation between time of symptom onset of ST-segment elevation myocardial infarction and patient baseline characteristics: from the National Cardiovascular Data Registry. Clin Cardiol. 2013 Apr;36(4):222-7. doi: 10.1002/clc.12101. Epub 2013 Mar 20.
Ofman P, Khawaja O, Rahilly-Tierney CR, Peralta A, Hoffmeister P, Reynolds MR, Gaziano JM, Djousse L. Regular physical activity and risk of atrial fibrillation: a systematic review and meta-analysis. Circ Arrhythm Electrophysiol. 2013 Apr;6(2):252-6. doi: 10.1161/CIRCEP.113.000147. Epub 2013 Mar 20.
Saad F, Haider A, Doros G, Traish A. Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss. Obesity (Silver Spring). 2013 Oct;21(10):1975-81. doi: 10.1002/oby.20407. Epub 2013 Apr 22.
Gosev I, Nascimben L, Huang PH, Mauri L, Steigner M, Mizuguchi A, Shah AM, Aranki SF. Right ventricular perforation and pulmonary embolism with polymethylmethacrylate cement after percutaneous kyphoplasty. Circulation. 2013 Mar 19;127(11):1251-3. doi: 10.1161/CIRCULATIONAHA.112.144535.
Reynolds MR. Interpreting the g loadings of intelligence test composite scores in light of Spearman’s law of diminishing returns. Sch Psychol Q. 2013 Mar;28(1):63-76. doi: 10.1037/spq0000013.
Januzzi JL Jr. Natriuretic peptides, ejection fraction, and prognosis: parsing the phenotypes of heart failure. J Am Coll Cardiol. 2013 Apr 9;61(14):1507-9. doi: 10.1016/j.jacc.2013.01.039.
Mega JL, Braunwald E, Murphy SA, Plotnikov AN, Burton P, Kiss RG, Parkhomenko A, Tendera M, Widimsky P, Gibson CM. Rivaroxaban in patients stabilized after a ST-segment elevation myocardial infarction: results from the ATLAS ACS-2-TIMI-51 trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction-51). J Am Coll Cardiol. 2013 May 7;61(18):1853-9. doi: 10.1016/j.jacc.2013.01.066. Epub 2013 Mar 7.
Reynolds MR, Cohen DJ. Reply: To PMID 23122802. J Am Coll Cardiol. 2013 Apr 23;61(16):1748. doi: 10.1016/j.jacc.2013.01.010.
Ghoshhajra BB, Lee AM, Ferencik M, Elmariah S, Margey RJ, Onuma O, Panagia M, Abbara S, Hoffmann U. Interpreting the interpretations: the use of structured reporting improves referring clinicians’ comprehension of coronary CT angiography reports. J Am Coll Radiol. 2013 Jun;10(6):432-8. doi: 10.1016/j.jacr.2012.11.012. Epub 2013 Feb 26.
Chhatriwalla AK, Amin AP, Kennedy KF, House JA, Cohen DJ, Rao SV, Messenger JC, Marso SP; National Cardiovascular Data Registry. Association between bleeding events and in-hospital mortality after percutaneous coronary intervention. JAMA. 2013 Mar 13;309(10):1022-9. doi: 10.1001/jama.2013.1556.
Clair C, Rigotti NA, Porneala B, Fox CS, D’Agostino RB, Pencina MJ, Meigs JB. Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes. JAMA. 2013 Mar 13;309(10):1014-21. doi: 10.1001/jama.2013.1644.
Jacobs AK, Normand SL, Massaro JM, Cutlip DE, Carrozza JP Jr, Marks AD, Murphy N, Romm IK, Biondolillo M, Mauri L; MASS COMM Investigators. Nonemergency PCI at hospitals with or without on-site cardiac surgery. N Engl J Med. 2013 Apr 18;368(16):1498-508. doi: 10.1056/NEJMoa1300610. Epub 2013 Mar 11.
Bhatt DL, Stone GW, Mahaffey KW, Gibson CM, Steg PG, Hamm CW, Price MJ, Leonardi S, Gallup D, Bramucci E, Radke PW, Widimský P, Tousek F, Tauth J, Spriggs D, McLaurin BT, Angiolillo DJ, Généreux P, Liu T, Prats J, Todd M, Skerjanec S, White HD, Harrington RA; CHAMPION PHOENIX Investigators. Effect of platelet inhibition with cangrelor during PCI on ischemic events. N Engl J Med. 2013 Apr 4;368(14):1303-13. doi: 10.1056/NEJMoa1300815. Epub 2013 Mar 10.
Farooq V, Vranckx P, Mauri L, Cutlip DE, Belardi J, Silber S, Widimsky P, Leon M, Windecker S, Meredith I, Negoita M, van Leeuwen F, Neumann FJ, Yeung AC, Garcia-Garcia HM, Serruys PW. Impact of overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: pooled analysis of five trials from the international Global RESOLUTE Program. Heart. 2013 May;99(9):626-33. doi: 10.1136/heartjnl-2012-303368. Epub 2013 Mar 6.
Leonardi S, Stebbins A, Lopes RD, Lokhnygina Y, Todd M, Bhatt DL, Stone GW, Lincoff AM, Dauerman HL, Gibson CM, White HD, Parikh KH, Gruberg L, Herrmann HC, McLaurin BT, Goodman SG, Mahaffey KW. Quantification of the effect of clopidogrel on enzymatic infarct size related to a percutaneous coronary intervention in patients with acute coronary syndromes: insights from the CHAMPION percutaneous coronary intervention trial. Coron Artery Dis. 2013 Jun;24(4):321-7. doi: 10.1097/MCA.0b013e32835f2fbd.
Leonardi S, Truffa AA, Neely ML, Tricoci P, White HD, Gibson CM, Wilson M, Stone GW, Harrington RA, Bhatt DL, Mahaffey KW. A novel approach to systematically implement the universal definition of myocardial infarction: insights from the CHAMPION PLATFORM trial. Heart. 2013 Sep;99(17):1282-7. doi: 10.1136/heartjnl-2012-303103. Epub 2013 Feb 23.
Kremers MS, Hammill SC, Berul CI, Koutras C, Curtis JS, Wang Y, Beachy J, Blum Meisnere L, Conyers del M, Reynolds MR, Heidenreich PA, Al-Khatib SM, Pina IL, Blake K, Norine Walsh M, Wilkoff BL, Shalaby A, Masoudi FA, Rumsfeld J. The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011. Heart Rhythm. 2013 Apr;10(4):e59-65. doi: 10.1016/j.hrthm.2013.01.035. Epub 2013 Feb 9.
Reynolds MR. Discontinuation of rivaroxaban: filling in the gaps. J Am Coll Cardiol. 2013 Feb 12;61(6):659-60. doi: 10.1016/j.jacc.2012.09.056.
Zigler CM, Watts K, Yeh RW, Wang Y, Coull BA, Dominici F. Model feedback in Bayesian propensity score estimation. Biometrics. 2013 Mar;69(1):263-73. doi: 10.1111/j.1541-0420.2012.01830.x. Epub 2013 Feb 4.
Steen DL, Cannon CP, Lele SS, Rajapurkar MM, Mukhopadhyay B, Scirica BM, Murphy SA, Morrow DA. Prognostic evaluation of catalytic iron in patients with acute coronary syndromes. Clin Cardiol. 2013 Mar;36(3):139-45. doi: 10.1002/clc.22089. Epub 2013 Feb 3.
Cannon CP, Brindis RG, Chaitman BR, Cohen DJ, Cross JT Jr, Drozda JP Jr, Fesmire FM, Fintel DJ, Fonarow GC, Fox KA, Gray DT, Harrington RA, Hicks KA, Hollander JE, Krumholz H, Labarthe DR, Long JB, Mascette AM, Meyer C, Peterson ED, Radford MJ, Roe MT, Richmann JB, Selker HP, Shahian DM, Shaw RE, Sprenger S, Swor R, Underberg JA, Van de Werf F, Weiner BH, Weintraub WS. 2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on clinical data standards (writing committee to develop acute coronary syndromes and coronary artery disease clinical data standards). J Am Coll Cardiol. 2013 Mar 5;61(9):992-1025. doi: 10.1016/j.jacc.2012.10.005. Epub 2013 Jan 28.
Kandzari DE, Teirstein PS, Kereiakes DJ, Cannon LA, Hearne SE, Kuo HC, Ying SW, Cheong WF, Popma JJ. Procedural effectiveness of a novel 1.20 mm diameter angioplasty catheter: clinical and angiographic outcomes. J Interv Cardiol. 2013 Apr;26(2):131-6. doi: 10.1111/j.1540-8183.2013.12021.x. Epub 2013 Jan 31.
Reardon MJ, Reynolds MR. Cost-effectiveness of TAVR in the non-surgical population. J Med Econ. 2013;16(4):575-9. doi: 10.3111/13696998.2013.772753. Epub 2013 Feb 12.
Oziminski WP, Palusiak M, Dominikowska J, Krygowski TM, Havenith RW, Gibson CM, Fowler PW. Capturing the elusive aromaticity of bicalicene. Phys Chem Chem Phys. 2013 Mar 7;15(9):3286-93. doi: 10.1039/c2cp43426a. Epub 2013 Jan 29.
Cannon CP, Brindis RG, Chaitman BR, Cohen DJ, Cross JT Jr, Drozda JP Jr, Fesmire FM, Fintel DJ, Fonarow GC, Fox KA, Gray DT, Harrington RA, Hicks KA, Hollander JE, Krumholz H, Labarthe DR, Long JB, Mascette AM, Meyer C, Peterson ED, Radford MJ, Roe MT, Richmann JB, Selker HP, Shahian DM, Shaw RE, Sprenger S, Swor R, Underberg JA, Van de Werf F, Weiner BH, Weintraub WS; American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards; American College of Emergency Physicians; Emergency Nurses Association; National Association of Emergency Medical Technicians; National Association of EMS Physicians; Preventive Cardiovascular Nurses Association; Society for Cardiovascular Angiography and Interventions; Society of Cardiovascular Patient Care; Society of Thoracic Surgeons. 2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Acute Coronary Syndromes and Coronary Artery Disease Clinical Data Standards). Circulation. 2013 Mar 5;127(9):1052-89. doi: 10.1161/CIR.0b013e3182831a11. Epub 2013 Jan 28.
Januzzi JL, Troughton R. Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure management. Circulation. 2013 Jan 29;127(4):500-7; discussion 508. doi: 10.1161/CIRCULATIONAHA.112.120485.
Doros G, Pencina M, Rybin D, Meisner A, Fava M. A repeated measures model for analysis of continuous outcomes in sequential parallel comparison design studies. Stat Med. 2013 Jul 20;32(16):2767-89. doi: 10.1002/sim.5728. Epub 2013 Jan 27.
Hassan S, Karpova Y, Baiz D, Yancey D, Pullikuth A, Flores A, Register T, Cline JM, D’Agostino R Jr, Danial N, Datta SR, Kulik G. Behavioral stress accelerates prostate cancer development in mice. J Clin Invest. 2013 Feb;123(2):874-86. doi: 10.1172/JCI63324. Epub 2013 Jan 25.
Mercado N, Cohen DJ, Spertus JA, Chan PS, House J, Kennedy K, Brindis RG, White CJ, Rosenfield KA, Marso SP. Carotid artery stenting of a contralateral occlusion and in-hospital outcomes: results from the CARE (Carotid Artery Revascularization and Endarterectomy) registry. JACC Cardiovasc Interv. 2013 Jan;6(1):59-64. doi: 10.1016/j.jcin.2012.09.009.
Nath AK, Roberts LD, Liu Y, Mahon SB, Kim S, Ryu JH, Werdich A, Januzzi JL, Boss GR, Rockwood GA, MacRae CA, Brenner M, Gerszten RE, Peterson RT. Chemical and metabolomic screens identify novel biomarkers and antidotes for cyanide exposure. FASEB J. 2013 May;27(5):1928-38. doi: 10.1096/fj.12-225037. Epub 2013 Jan 23.
Greenberg JO, Vakharia N, Szent-Gyorgyi LE, Desai SP, Turchin A, Forman J, Bonventre JV, Kachalia A. Meaningful measurement: developing a measurement system to improve blood pressure control in patients with chronic kidney disease. J Am Med Inform Assoc. 2013 Jun;20(e1):e97-e101. doi: 10.1136/amiajnl-2012-001308. Epub 2013 Jan 23.
Rosen J, Lawrence R, Bouchard M, Doros G, Gardiner P, Saper R. Massage for perioperative pain and anxiety in placement of vascular access devices. Adv Mind Body Med. 2013 Winter;27(1):12-23.
Preis SR, Pencina MJ, Mann DM, D’Agostino RB Sr, Savage PJ, Fox CS. Early-adulthood cardiovascular disease risk factor profiles among individuals with and without diabetes in the Framingham Heart Study. Diabetes Care. 2013 Jun;36(6):1590-6. doi: 10.2337/dc12-1121. Epub 2013 Jan 22.
Farber A, Tan TW, Rybin D, Kalish JA, Hamburg NM, Doros G, Goodney PP, Cronenwett JL; Vascular Study Group of New England. Intraoperative use of dextran is associated with cardiac complications after carotid endarterectomy. J Vasc Surg. 2013 Mar;57(3):635-41. doi: 10.1016/j.jvs.2012.09.017. Epub 2013 Jan 18.
Orenes-Piñero E, Manzano-Fernández S, López-Cuenca Á, Marín F, Valdés M, Januzzi JL. β-Trace protein: from GFR marker to cardiovascular risk predictor. Clin J Am Soc Nephrol. 2013 May;8(5):873-81. doi: 10.2215/CJN.08870812. Epub 2013 Jan 18.
Mebazaa A, Gayat E, Lassus J, Meas T, Mueller C, Maggioni A, Peacock F, Spinar J, Harjola VP, van Kimmenade R, Pathak A, Mueller T, Tavazzi L, Disomma S, Metra M, Pascual-Figal D, Laribi S, Logeart D, Nouira S, Sato N, Parenica J, Deye N, Boukef R, Collet C, Van den Berghe G, Cohen-Solal A, Januzzi JL Jr; GREAT Network. Association between elevated blood glucose and outcome in acute heart failure: results from an international observational cohort. J Am Coll Cardiol. 2013 Feb 26;61(8):820-9. doi: 10.1016/j.jacc.2012.11.054. Epub 2013 Jan 16.
Pride YB, Cutlip DE. Disappearing stents–DREAMS of a sorcerer’s apprentice?. Lancet. 2013 Mar 9;381(9869):787-9. doi: 10.1016/S0140-6736(12)62036-4.
Ahmed W, Schlett CL, Uthamalingam S, Truong QA, Koenig W, Rogers IS, Blankstein R, Nagurney JT, Tawakol A, Januzzi JL, Hoffmann U. Single resting hsTnT level predicts abnormal myocardial stress test in acute chest pain patients with normal initial standard troponin. JACC Cardiovasc Imaging. 2013 Jan;6(1):72-82. doi: 10.1016/j.jcmg.2012.08.014.
Geltman PL, Adams JH, Cochran J, Doros G, Rybin D, Henshaw M, Barnes LL, Paasche-Orlow M. The impact of functional health literacy and acculturation on the oral health status of Somali refugees living in Massachusetts. Am J Public Health. 2013 Aug;103(8):1516-23. doi: 10.2105/AJPH.2012.300885. Epub 2013 Jan 17.
Reynolds MR, Nilsson J, Akerborg O, Jhaveri M, Lindgren P. Cost-effectiveness of dronedarone and standard of care compared with standard of care alone: US results of an ATHENA lifetime model. Clinicoecon Outcomes Res. 2013;5:19-28. doi: 10.2147/CEOR.S36019. Epub 2013 Jan 8.
Jacques PF, Lyass A, Massaro JM, Vasan RS, D’Agostino RB Sr. Relationship of lycopene intake and consumption of tomato products to incident CVD. Br J Nutr. 2013 Aug 28;110(3):545-51. doi: 10.1017/S0007114512005417. Epub 2013 Jan 15.
Gaggin HK, Januzzi JL Jr. Biomarkers and diagnostics in heart failure. Biochim Biophys Acta. 2013 Dec;1832(12):2442-50. doi: 10.1016/j.bbadis.2012.12.014. Epub 2013 Jan 9.
Bouchard DR, Porneala B, Janssen I, Langlois MF, Baillargeon JP, Fox CS, Meigs JB, D’Agostino RB Sr, Pencina M, Hivert MF. Risk of type 2 diabetes and cumulative excess weight exposure in the Framingham Offspring Study. J Diabetes Complications. 2013 May-Jun;27(3):214-8. doi: 10.1016/j.jdiacomp.2012.11.009. Epub 2013 Jan 10.
Zannad F, Stough WG, Regnault V, Gheorghiade M, Deliargyris E, Gibson CM, Agewall S, Berkowitz SD, Burton P, Calvo G, Goldstein S, Verheugt FW, Koglin J, O’Connor CM. Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges. Int J Cardiol. 2013 Sep 1;167(5):1772-82. doi: 10.1016/j.ijcard.2012.12.018. Epub 2013 Jan 6.
Beach SR, Celano CM, Noseworthy PA, Januzzi JL, Huffman JC. QTc prolongation, torsades de pointes, and psychotropic medications. Psychosomatics. 2013 Jan-Feb;54(1):1-13. doi: 10.1016/j.psym.2012.11.001.
Herzig SJ, Rothberg MB, Feinbloom DB, Howell MD, Ho KK, Ngo LH, Marcantonio ER. Risk factors for nosocomial gastrointestinal bleeding and use of acid-suppressive medication in non-critically ill patients. J Gen Intern Med. 2013 May;28(5):683-90. doi: 10.1007/s11606-012-2296-x. Epub 2013 Jan 5.
Reynolds MR, Cohen DJ. Reply: To PMID 22818074. J Am Coll Cardiol. 2013 Jan 8;61(1):108-9. doi: 10.1016/j.jacc.2012.09.029.
Gaggin HK, Truong QA, Rehman SU, Mohammed AA, Bhardwaj A, Parks KA, Sullivan DA, Chen-Tournoux A, Moore SA, Richards AM, Troughton RW, Lainchbury JG, Weiner RB, Baggish AL, Semigran MJ, Januzzi JL Jr. Characterization and prediction of natriuretic peptide “nonresponse” during heart failure management: results from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) and the NT-proBNP-Assisted Treatment to Lessen Serial Cardiac Readmissions and Death (BATTLESCARRED) study. Congest Heart Fail. 2013 May-Jun;19(3):135-42. doi: 10.1111/chf.12016. Epub 2012 Dec 28.
Kohli P, Wallentin L, Reyes E, Horrow J, Husted S, Angiolillo DJ, Ardissino D, Maurer G, Morais J, Nicolau JC, Oto A, Storey RF, James SK, Cannon CP. Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study. Circulation. 2013 Feb 12;127(6):673-80. doi: 10.1161/CIRCULATIONAHA.112.124248. Epub 2012 Dec 31.
Pride YB, Piccirillo BJ, Gibson CM. Prevalence, consequences, and implications for clinical trials of unrecognized myocardial infarction. Am J Cardiol. 2013 Mar 15;111(6):914-8. doi: 10.1016/j.amjcard.2012.11.042. Epub 2012 Dec 28.
Schlett CL, Truong QA, Ahmed W, Blankstein R, Ferencik M, Uthamalingam S, Bamberg F, Koenig W, Januzzi JL, Hoffmann U. High-sensitivity troponin T and C-reactive protein to identify patients without cardiac structural and functional abnormalities as assessed by cardiac CT and SPECT imaging: can biomarkers predict cardiac health?. Int J Cardiovasc Imaging. 2013 Apr;29(4):865-73. doi: 10.1007/s10554-012-0164-8. Epub 2013 Jan 1.
Berman DS, Maddahi J, Tamarappoo BK, Czernin J, Taillefer R, Udelson JE, Gibson CM, Devine M, Lazewatsky J, Bhat G, Washburn D. Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 positron emission tomography. J Am Coll Cardiol. 2013 Jan 29;61(4):469-477. doi: 10.1016/j.jacc.2012.11.022. Epub 2012 Dec 19.
Preis SR, Pencina MJ, D’Agostino RB Sr, Meigs JB, Vasan RS, Fox CS. Neck circumference and the development of cardiovascular disease risk factors in the Framingham Heart Study. Diabetes Care. 2013 Jan;36(1):e3. doi: 10.2337/dc12-0738.
Galper BZ, Mauri L. Antiplatelet therapy after coronary stenting. Curr Treat Options Cardiovasc Med. 2013 Feb;15(1):1-10. doi: 10.1007/s11936-012-0223-4.
Li M, Huang WE, Gibson CM, Fowler PW, Jousset A. Stable isotope probing and Raman spectroscopy for monitoring carbon flow in a food chain and revealing metabolic pathway. Anal Chem. 2013 Feb 5;85(3):1642-9. doi: 10.1021/ac302910x. Epub 2013 Jan 14.
Garg R, Hurwitz S, Turchin A, Trivedi A. Hypoglycemia, with or without insulin therapy, is associated with increased mortality among hospitalized patients. Diabetes Care. 2013 May;36(5):1107-10. doi: 10.2337/dc12-1296. Epub 2012 Dec 17.
Niileksela CR, Reynolds MR, Kaufman AS. An alternative Cattell-Horn-Carroll (CHC) factor structure of the WAIS-IV: age invariance of an alternative model for ages 70-90. Psychol Assess. 2013 Jun;25(2):391-404. doi: 10.1037/a0031175. Epub 2012 Dec 17.
Pencina MJ, D’Agostino RB, Massaro JM. Understanding increments in model performance metrics. Lifetime Data Anal. 2013 Apr;19(2):202-18. doi: 10.1007/s10985-012-9238-0. Epub 2012 Dec 16.
Rosenberg MA, Samuel M, Thosani A, Zimetbaum PJ. Use of a noninvasive continuous monitoring device in the management of atrial fibrillation: a pilot study. Pacing Clin Electrophysiol. 2013 Mar;36(3):328-33. doi: 10.1111/pace.12053. Epub 2012 Dec 13.
Arnold SV, Spertus JA, Lei Y, Allen KB, Chhatriwalla AK, Leon MB, Smith CR, Reynolds MR, Webb JG, Svensson LG, Cohen DJ. Use of the Kansas City Cardiomyopathy Questionnaire for monitoring health status in patients with aortic stenosis. Circ Heart Fail. 2013 Jan;6(1):61-7. doi: 10.1161/CIRCHEARTFAILURE.112.970053. Epub 2012 Dec 10.
Morrison F, Shubina M, Goldberg SI, Turchin A. Performance of primary care physicians and other providers on key process measures in the treatment of diabetes. Diabetes Care. 2013 May;36(5):1147-52. doi: 10.2337/dc12-1382. Epub 2012 Dec 10.
Nazer B, Ray KK, Murphy SA, Gibson CM, Cannon CP. Urinary albumin concentration and long-term cardiovascular risk in acute coronary syndrome patients: a PROVE IT-TIMI 22 substudy. J Thromb Thrombolysis. 2013 Oct;36(3):233-9. doi: 10.1007/s11239-012-0853-0.
Salisbury AC, Wang K, Cohen DJ, Li Y, Jones PG, Spertus JA. Selecting antiplatelet therapy at the time of percutaneous intervention for an acute coronary syndrome: weighing the benefits and risks of prasugrel versus clopidogrel. Circ Cardiovasc Qual Outcomes. 2013 Jan 1;6(1):27-34. doi: 10.1161/CIRCOUTCOMES.112.965624. Epub 2012 Dec 4.
Motiwala SR, Januzzi JL Jr. The role of natriuretic peptides as biomarkers for guiding the management of chronic heart failure. Clin Pharmacol Ther. 2013 Jan;93(1):57-67. doi: 10.1038/clpt.2012.187. Epub 2012 Nov 28.
Davidson M, Liu SX, Barter P, Brinton EA, Cannon CP, Gotto AM Jr, Leary ET, Shah S, Stepanavage M, Mitchel Y, Dansky HM. Measurement of LDL-C after treatment with the CETP inhibitor anacetrapib. J Lipid Res. 2013 Feb;54(2):467-72. doi: 10.1194/jlr.M032615. Epub 2012 Nov 19.
Villamar MF, Contreras VS, Kuntz RE, Fregni F. The reporting of blinding in physical medicine and rehabilitation randomized controlled trials: a systematic review. J Rehabil Med. 2013 Jan;45(1):6-13. doi: 10.2340/16501977-1071.
Kumbhani DJ, Steg PG, Cannon CP, Eagle KA, Smith SC Jr, Crowley K, Goto S, Ohman EM, Bakris GL, Perlstein TS, Kinlay S, Bhatt DL; REACH Registry Investigators. Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis. Eur Heart J. 2013 Apr;34(16):1204-14. doi: 10.1093/eurheartj/ehs368. Epub 2012 Nov 9.
Rassi AN, Cavender MA, Fonarow GC, Cannon CP, Hernandez AF, Peterson ED, Peacock WF, Laskey WK, Rosas SE, Zhao X, Schwamm LH, Bhatt DL. Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction. J Am Coll Cardiol. 2013 Jan 8;61(1):35-40. doi: 10.1016/j.jacc.2012.08.1019. Epub 2012 Nov 5.
Zafar MU, Santos-Gallego C, Vorchheimer DA, Viles-Gonzalez JF, Elmariah S, Giannarelli C, Sartori S, Small DS, Jakubowski JA, Fuster V, Badimon JJ. Platelet function normalization after a prasugrel loading-dose: time-dependent effect of platelet supplementation. J Thromb Haemost. 2013 Jan;11(1):100-6. doi: 10.1111/jth.12058.
Weiner RB, Baggish AL, Chen-Tournoux A, Marshall JE, Gaggin HK, Bhardwaj A, Mohammed AA, Rehman SU, Barajas L, Barajas J, Gregory SA, Moore SA, Semigran MJ, Januzzi JL Jr. Improvement in structural and functional echocardiographic parameters during chronic heart failure therapy guided by natriuretic peptides: mechanistic insights from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) study. Eur J Heart Fail. 2013 Mar;15(3):342-51. doi: 10.1093/eurjhf/hfs180. Epub 2012 Nov 6.
Abdelhadi RH, Saba SF, Ellis CR, Mason PK, Kramer DB, Friedman PA, Gura MT, DiMarco JP, Mugglin AS, Reynolds MR, Bazaz RR, Retel LK, Hayes DL, Hauser RG. Independent multicenter study of Riata and Riata ST implantable cardioverter-defibrillator leads. Heart Rhythm. 2013 Mar;10(3):361-5. doi: 10.1016/j.hrthm.2012.10.045. Epub 2012 Nov 2.
Jasuja GK, Travison TG, Davda M, Murabito JM, Basaria S, Zhang A, Kushnir MM, Rockwood AL, Meikle W, Pencina MJ, Coviello A, Rose AJ, D’Agostino R, Vasan RS, Bhasin S. Age trends in estradiol and estrone levels measured using liquid chromatography tandem mass spectrometry in community-dwelling men of the Framingham Heart Study. J Gerontol A Biol Sci Med Sci. 2013 Jun;68(6):733-40. doi: 10.1093/gerona/gls216. Epub 2012 Oct 25.
Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB; Valve Academic Research Consortium-2. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg. 2013 Jan;145(1):6-23. doi: 10.1016/j.jtcvs.2012.09.002. Epub 2012 Oct 16.
Murphy RK, Reynolds MR, Mansur DB, Smyth MD. Gamma knife surgery for a hemangioma of the cavernous sinus in a child. J Neurosurg Pediatr. 2013 Jan;11(1):74-8. doi: 10.3171/2012.9.PEDS12213. Epub 2012 Oct 19.
Yeh GY, Wood MJ, Wayne PM, Quilty MT, Stevenson LW, Davis RB, Phillips RS, Forman DE. Tai chi in patients with heart failure with preserved ejection fraction. Congest Heart Fail. 2013 Mar-Apr;19(2):77-84. doi: 10.1111/chf.12005. Epub 2012 Oct 12.
Dmitrienko A, D’Agostino RB Sr, Huque MF. Key multiplicity issues in clinical drug development. Stat Med. 2013 Mar 30;32(7):1079-111. doi: 10.1002/sim.5642. Epub 2012 Oct 9.
Desai SP, Lu B, Szent-Gyorgyi LE, Bogdanova AA, Turchin A, Weinblatt M, Coblyn J, Greenberg JO, Kachalia A, Solomon DH. Increasing pneumococcal vaccination for immunosuppressed patients: a cluster quality improvement trial. Arthritis Rheum. 2013 Jan;65(1):39-47. doi: 10.1002/art.37716.
Motiwala SR, Januzzi JL Jr. Using biomarkers to “guide” heart failure management: current perspectives and future directions. Cardiol Rev. 2013 May-Jun;21(3):127-34. doi: 10.1097/CRD.0b013e3182769073.
Vranckx P, McFadden E, Cutlip DE, Mehran R, Swart M, Kint PP, Zijlstra F, Silber S, Windecker S, Serruys PW. Clinical endpoint adjudication in a contemporary all-comers coronary stent investigation: methodology and external validation. Contemp Clin Trials. 2013 Jan;34(1):53-9. doi: 10.1016/j.cct.2012.08.012. Epub 2012 Sep 10.
Kimokoti RW, Newby PK, Gona P, Zhu L, McKeon-O’Malley C, Pablo Guzman J, D’Agostino RB, Millen BE. Patterns of weight change and progression to overweight and obesity differ in men and women: implications for research and interventions. Public Health Nutr. 2013 Aug;16(8):1463-75. doi: 10.1017/S1368980012003801. Epub 2012 Aug 31.
Charytan DM, Garg P, Varma M, Garshick MS, Jeon C, Mauri L. Angiographic characteristics of coronary arterial segments progressing to myocardial infarction in patients with and without chronic kidney disease. Clin Exp Nephrol. 2013 Apr;17(2):232-9. doi: 10.1007/s10157-012-0682-7. Epub 2012 Aug 29.
Kumbhani DJ, Fonarow GC, Cannon CP, Hernandez AF, Peterson ED, Peacock WF, Laskey WK, Pan W, Schwamm LH, Bhatt DL; Get With the Guidelines Steering Committee and Investigators. Predictors of adherence to performance measures in patients with acute myocardial infarction. Am J Med. 2013 Jan;126(1):74.e1-9. doi: 10.1016/j.amjmed.2012.02.025. Epub 2012 Aug 24.
Smith K, deFilippi C, Isakova T, Gutiérrez OM, Laliberte K, Seliger S, Kelley W, Duh SH, Hise M, Christenson R, Wolf M, Januzzi J. Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD. Am J Kidney Dis. 2013 Jan;61(1):67-73. doi: 10.1053/j.ajkd.2012.06.022. Epub 2012 Aug 9.
Kadkhodayan Y, Shetty VS, Blackburn SL, Reynolds MR, Cross DT 3rd, Moran CJ. Pipeline embolization device and subsequent vessel sacrifice for treatment of a bleeding carotid pseudoaneurysm at the skull base: a case report. J Neurointerv Surg. 2013 Sep 1;5(5):e31. doi: 10.1136/neurintsurg-2012-010394. Epub 2012 Jul 28.
Li H, Sankoh AJ, D’Agostino RB Sr. Extension of adaptive alpha allocation methods for strong control of the family-wise error rate. Stat Med. 2013 Jan 30;32(2):181-95. doi: 10.1002/sim.5485. Epub 2012 Jul 16.
Lopes RD, White JA, Tricoci P, White HD, Armstrong PW, Braunwald E, Giugliano RP, Harrington RA, Lewis BS, Brogan GX Jr, Gibson CM, Califf RM, Newby LK. Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: insights from the EARLY ACS trial. Int J Cardiol. 2013 Sep 10;167(6):2580-7. doi: 10.1016/j.ijcard.2012.06.053. Epub 2012 Jul 13.
Kohli P, Cannon CP. Dabigatran associated with increased risk of acute coronary events. Evid Based Med. 2013 Feb;18(1):e9. doi: 10.1136/eb-2012-100733. Epub 2012 Jun 27.
Cowan AJ, Skinner M, Seldin DC, Berk JL, Lichtenstein DR, O’Hara CJ, Doros G, Sanchorawala V. Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experience. Haematologica. 2013 Jan;98(1):141-6. doi: 10.3324/haematol.2012.068155. Epub 2012 Jun 24.
Akbari SH, Reynolds MR, Kadkhodayan Y, Cross DT 3rd, Moran CJ. Hemorrhagic complications after prasugrel (Effient) therapy for vascular neurointerventional procedures. J Neurointerv Surg. 2013 Jul;5(4):337-43. doi: 10.1136/neurintsurg-2012-010334. Epub 2012 May 3.
Blankenship JC, Marshall JJ, Pinto DS, Lange RA, Bates ER, Holper EM, Grines CL, Chambers CE; Society for Cardiovascular Angiography and Interventions. Effect of percutaneous coronary intervention on quality of life: a consensus statement from the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2013 Feb;81(2):243-59. doi: 10.1002/ccd.24376. Epub 2012 Apr 27.
Abedi G, Doros G, Subramanian ML. Transitioning from Stratus OCT to Cirrus OCT using Lin’s concordance coefficient. Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):411-2. doi: 10.1007/s00417-011-1899-y. Epub 2012 Jan 4.